Table 1.
Baseline Characteristics and Lab Investigations of the COVID-19 Patients
| Demographics | |
|---|---|
| Age [mean ± SD] | 53.2±13.8 (Range 28–77 years) |
| Sex (Male%/Female%) | 76%/24% |
| Duration of positive test to admission (Lag time) | 1 (Range 0–10) |
| Prevalence of diabetes [%] | 38% |
| Prevalence of kidney disease at presentation (eGFR <60 mL) (CKD EPI) [N%] | 8/44 (20%) |
| Prevalence of liver injury (AST and or ALT >ULN) [N%] | 27/44 (61.3%) |
| Prevalence of liver injury (AST and or ALT > 3x ULN) [N%] | 6/44 (14%) |
| Investigations | Results |
| Haematology | |
| Haemoglobin (g/dl) | 12.68 (8.9–17.3) |
| TLC (/ul) | 8820 (2700–18200) |
| Neutrophil (%) | 70 (16–91) |
| Lymphocyte (%) | 23.1 (3–90) |
| Biochemistry | |
| BUN (mg/dl) | 18 (7–50) |
| Serum creatinine (mg/dl) | 1.0 (0.6–1.95) |
| AST (IU/L) | 67 (18–383) |
| ALT (IU/L) | 61 (19–379) |
| Inflammatory markers | |
| Interleukin 6 (pg/mL) | 259 (6–2270) |
| C reactive protein | 34 (3.0–195) |
| D Dimer (ng/mL) | 1673 (100–10000) |
| Vitals at presentation | |
| Blood pressure | |
| Systolic (mmHg) | 126±15 (80–168) |
| Diastolic (mmHg) | 80±7 (62–95) |
| Pulse rate (Per minute) | 89±15 (63–100) |
| Respiratory rate (Per/Minute) | 22±4 (18–34) |
| SpO2 (%) | 93±6 (68–100) |
| Saturation <94% on the time of admission | 16/50 (32%) |